| Melissa A Lawson, MD | |
|
404 N Keene St Ste 101, Columbia, MO 65201-6626 | |
| (573) 882-6921 | |
| (573) 884-5226 |
| Full Name | Melissa A Lawson |
|---|---|
| Gender | Female |
| Speciality | Pediatric Medicine |
| Experience | 31 Years |
| Location | 404 N Keene St Ste 101, Columbia, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023063807 | NPI | - | NPPES |
| 204683403 | Medicaid | MO | |
| 128865 | Other | MO | BLUE SHIELD/BLUE CHOICE |
| 370014794 | Other | MO | RR MEDICARE |
| 413884 | Other | MO | HEALTHLINK |
| 1201230 | Other | MO | UNITED HEALTHCARE |
| 2086801901 | Other | KS | KANSAS MEDICAID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD119697 (Missouri) | Secondary |
| 2080A0000X | Pediatrics - Adolescent Medicine | 119697 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Curators Of The University Of Missouri | 4486759560 | 959 |
News Archive
As part of the Target Safely initiative, the American Society for Radiation Oncology (ASTRO) has developed a white paper, the first of a series of such papers, on the safe use of integrating intensity modulated radiation therapy (IMRT) into the radiation oncology clinic.
Researchers at The Children's Hospital of Philadelphia have manipulated cell activity that occurs during the interruption of blood flow to strongly protect heart tissue in animal studies. The finding has the potential to become an emergency treatment for heart attack patients, particularly since already existing drugs might be pressed into service to produce the protective effects.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated patient enrollment in an open-label, multi-center Phase 1b clinical trial evaluating tivozanib in combination with oral capecitabine (Xeloda®) in patients with certain advanced solid tumors.
Helix BioMedix, Inc., a developer of bioactive peptides, announced additional funding in the amount of $2.9 million through convertible promissory notes. The company also announced the addition of Lawrence Blake Jones to its board of directors.
Patients who take prescription opioids for a longer period before spinal surgery are more likely to continue using opioids several months after surgery, reports a study in the June 6, 2018, issue of The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.
› Verified 8 days ago
| Entity Name | The Curators Of The University Of Missouri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235126921 PECOS PAC ID: 4486759560 Enrollment ID: O20070418000290 |
News Archive
As part of the Target Safely initiative, the American Society for Radiation Oncology (ASTRO) has developed a white paper, the first of a series of such papers, on the safe use of integrating intensity modulated radiation therapy (IMRT) into the radiation oncology clinic.
Researchers at The Children's Hospital of Philadelphia have manipulated cell activity that occurs during the interruption of blood flow to strongly protect heart tissue in animal studies. The finding has the potential to become an emergency treatment for heart attack patients, particularly since already existing drugs might be pressed into service to produce the protective effects.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated patient enrollment in an open-label, multi-center Phase 1b clinical trial evaluating tivozanib in combination with oral capecitabine (Xeloda®) in patients with certain advanced solid tumors.
Helix BioMedix, Inc., a developer of bioactive peptides, announced additional funding in the amount of $2.9 million through convertible promissory notes. The company also announced the addition of Lawrence Blake Jones to its board of directors.
Patients who take prescription opioids for a longer period before spinal surgery are more likely to continue using opioids several months after surgery, reports a study in the June 6, 2018, issue of The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa A Lawson, MD Po Box 843966, Kansas City, MO 64184-3966 Ph: (573) 884-3300 | Melissa A Lawson, MD 404 N Keene St Ste 101, Columbia, MO 65201-6626 Ph: (573) 882-6921 |
News Archive
As part of the Target Safely initiative, the American Society for Radiation Oncology (ASTRO) has developed a white paper, the first of a series of such papers, on the safe use of integrating intensity modulated radiation therapy (IMRT) into the radiation oncology clinic.
Researchers at The Children's Hospital of Philadelphia have manipulated cell activity that occurs during the interruption of blood flow to strongly protect heart tissue in animal studies. The finding has the potential to become an emergency treatment for heart attack patients, particularly since already existing drugs might be pressed into service to produce the protective effects.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated patient enrollment in an open-label, multi-center Phase 1b clinical trial evaluating tivozanib in combination with oral capecitabine (Xeloda®) in patients with certain advanced solid tumors.
Helix BioMedix, Inc., a developer of bioactive peptides, announced additional funding in the amount of $2.9 million through convertible promissory notes. The company also announced the addition of Lawrence Blake Jones to its board of directors.
Patients who take prescription opioids for a longer period before spinal surgery are more likely to continue using opioids several months after surgery, reports a study in the June 6, 2018, issue of The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.
› Verified 8 days ago
Bailey M Clancy, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Hospital Drive Pediatrics Dc058.00, Columbia, MO 65212 Phone: 573-882-4438 Fax: 573-884-9992 | |
Daniela Cristina Bichianu, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 404 N Keene St, Columbia, MO 65201 Phone: 573-882-2272 Fax: 573-884-1795 | |
Dr. Danielle Renee Keebaugh, MD Pediatrics Medicare: Medicare Enrolled Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-6544 Fax: 573-882-2256 | |
Nathan K Beckett, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 404 N Keene St, Columbia, MO 65201 Phone: 573-882-4438 Fax: 573-884-9992 | |
Abdul-azeez Abdullahi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-4438 Fax: 573-884-9992 | |
Dr. Laura E. Henderson Kelley, M.D, MPH Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 101 S Fairview Rd, Columbia, MO 65203 Phone: 573-882-4464 |